Guangyao Kong
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 7
- Hepatology top 5%
- Liver Disease and Transplantation 6
- Hematology top 5%
- Acute Myeloid Leukemia Research 16
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 6
- RNA modifications and cancer 6
- Immunology top 10%
-
- Hepatitis B Virus Studies 10
- Liver Disease Diagnosis and Treatment 8
- Cited by
- Cancer ResearchHepatologyHematology
- Journals
- Journal of Biological Chemistry (7 papers)Blood (6 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Guangyao Kong
71 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 800
- Hepatology 189
- Hematology 224
- Molecular Biology 1.3k
- Immunology 327
Countries citing papers authored by Guangyao Kong
This map shows the geographic impact of Guangyao Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyao Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyao Kong more than expected).
Fields of papers citing papers by Guangyao Kong
This network shows the impact of papers produced by Guangyao Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyao Kong. The network helps show where Guangyao Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangyao Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 8 | |
| 12 | 2019 | 2 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 38 | |
| 15 | 2017 | 48 | |
| 16 | 2015 | 42 | |
| 17 | 2012 | 11 | |
| 18 | 2012 | 310 | |
| 19 | 2011 | 94 | |
| 20 | 1998 | 25 |
About Guangyao Kong
Guangyao Kong is a scholar working on Hematology, Hepatology and Biological Psychiatry, having authored 74 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Hepatitis B Virus Studies (10 papers), Epigenetics and DNA Methylation (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (7 papers), Liver Disease and Transplantation (6 papers), Cancer-related gene regulation (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (800 citations), Hepatology (189 citations) and Hematology (224 citations). Guangyao Kong has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaodong Zhang, Lihong Ye, Shuai Zhang, Yumei Du, Xiaona You, Changliang Shan, Yuen Gao, Junping Zhang, Tao Zhang and Erik A. Ranheim. Their work appears in journals such as Journal of Biological Chemistry, Blood, Frontiers in Immunology, Oncogene and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.